+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Pancreas Device System Market - Global Forecast 2026-2032- Product Image
Artificial Pancreas Device System Market - Global Forecast 2026-2032- Product Image
Sale

Artificial Pancreas Device System Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904638
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Pancreas Device System Market is projected to reach USD 418.22 Million in 2026. It is expected to continue growing at a CAGR of 8.74%, reaching USD 686.27 Million by 2032.

Artificial pancreas device systems (APDS), also known as automated insulin delivery or hybrid closed-loop systems, combine a continuous glucose monitor, insulin pump, and dosing algorithm to automate insulin adjustments for people living with insulin-dependent diabetes. These systems are moving diabetes management from reactive self-care toward predictive, data-driven therapy that can improve time in range, reduce hypoglycemia exposure, and lessen the burden of manual dosing decisions.

Demand is supported by the rising global diabetes burden, strong clinical evidence for closed-loop insulin delivery, and expanding regulatory pathways for interoperable diabetes devices. The International Diabetes Federation reports that hundreds of millions of adults live with diabetes worldwide, while type 1 diabetes continues to create a durable need for advanced insulin delivery technologies. For manufacturers, payers, providers, and digital health partners, the artificial pancreas device system market is increasingly defined by clinical outcomes, usability, reimbursement access, cybersecurity, algorithm performance, and equitable patient access.

Transformative Shifts in the Artificial Pancreas Landscape

The artificial pancreas device system landscape is being reshaped by the shift from standalone pumps and glucose sensors to interoperable diabetes technology ecosystems. Regulatory categories such as integrated continuous glucose monitors and alternate controller enabled insulin pumps have encouraged modular innovation, allowing qualified devices to communicate safely and support more flexible product combinations.

Another major shift is the movement from specialist-only adoption toward broader diabetes care pathways. Pediatric use, telehealth follow-up, remote monitoring, and pharmacy-supported education are expanding access, while payers increasingly evaluate automated insulin delivery based on measurable improvements in time in range, hypoglycemia reduction, hospital utilization, and long-term diabetes complication risk. At the same time, industry participants face pressure to lower device complexity, improve sensor wearability, extend infusion reliability, and support diverse populations historically underrepresented in diabetes technology trials.

Cumulative Impact of AI on Automated Insulin Delivery

Artificial intelligence is amplifying the value of artificial pancreas device systems by improving glucose forecasting, insulin dosing recommendations, anomaly detection, and personalization. Modern algorithms increasingly account for insulin-on-board, glucose trends, meal timing, exercise, sleep, stress, illness, and behavioral variability, enabling more adaptive therapy than fixed basal schedules.

The cumulative impact of AI extends beyond insulin automation. Machine learning can support sensor signal refinement, infusion-set failure detection, clinical decision support, population-level risk stratification, and real-world evidence generation from connected-device data. However, responsible AI deployment requires transparent validation, bias assessment, post-market monitoring, human factors testing, privacy safeguards, and cybersecurity controls, particularly because APDS decisions can directly affect patient safety.

Key Regional Insights Across Global APDS Markets

North America remains a leading region for artificial pancreas device system adoption due to early regulatory clearances, strong endocrinology and diabetes education networks, commercial and public payer coverage pathways, and a mature ecosystem of continuous glucose monitor and insulin pump users. The United States continues to anchor innovation and clinical adoption, while Canada benefits from provincial reimbursement progress, established diabetes care infrastructure, and growing awareness of automated insulin delivery benefits.

Europe is shaped by CE marking requirements, the European Medical Device Regulation, national health technology assessment processes, and increasing reimbursement recognition for hybrid closed-loop systems. The United Kingdom, Germany, France, Italy, and Spain are important adoption centers, with payer scrutiny focused on clinical outcomes, safety, usability, and budget impact. Asia-Pacific offers significant long-term patient opportunity because of the scale of diabetes prevalence in China and India, combined with high technology readiness, specialist capacity, and connected-device adoption in Japan, South Korea, and Australia.

Latin America shows rising interest in Brazil and Mexico, supported by expanding diabetes diagnosis and private healthcare access, but adoption remains constrained by reimbursement gaps, device affordability, and uneven access to endocrinology services. The Middle East, particularly affluent Gulf markets, is adopting premium diabetes technologies through advanced hospital systems, high diabetes awareness, and government investment in digital health. Africa’s adoption is more limited by affordability, insulin access, supply-chain resilience, and clinical infrastructure, creating opportunities for lower-cost, durable, mobile-enabled, and service-supported APDS solutions.

Key Group Insights for APDS Commercial Strategy

Within ASEAN, artificial pancreas device system adoption is uneven, with Singapore and Malaysia demonstrating stronger digital health readiness, specialist access, and private insurance support than lower-income markets where out-of-pocket costs remain a barrier. Local partnerships, distributor capability, physician training, and diabetes education programs are essential for scaling automated insulin delivery across diverse health systems.

The GCC represents a high-value market group because of elevated diabetes prevalence, government investment in specialty care, modern hospital infrastructure, and demand for connected health solutions. The European Union supports structured adoption through clinical evidence standards, privacy regulation, coordinated medical device oversight, and national reimbursement assessment, while BRICS economies combine large diabetes populations with price sensitivity, localization priorities, and growing domestic medtech capabilities.

G7 markets are central to premium artificial pancreas innovation, reimbursement evidence generation, clinical guideline development, and early adoption of interoperable diabetes technology platforms. NATO countries, while not a healthcare market bloc, share overlapping priorities in resilient medical supply chains, cybersecurity, trusted digital infrastructure, and continuity of care, which are increasingly relevant for connected insulin delivery devices and AI-enabled diabetes management systems.

Key Country Insights in Artificial Pancreas Adoption

The United States is one of the most influential artificial pancreas device system markets, supported by defined regulatory pathways, advanced endocrinology networks, broad continuous glucose monitor adoption, diabetes technology literacy, and payer experience with insulin pump reimbursement. Canada offers steady adoption through provincial coverage improvements and strong clinical infrastructure, while Mexico and Brazil provide sizable diabetes populations but require affordability strategies, payer engagement, local education, and differentiated channel models.

In Europe, the United Kingdom’s national health technology guidance has strengthened the case for hybrid closed-loop therapy in eligible people with type 1 diabetes, while Germany benefits from advanced reimbursement mechanisms, digital health readiness, and specialist-led adoption. France, Italy, and Spain are expanding access through national and regional evaluation processes, with adoption influenced by payer criteria, diabetes center capacity, and clinician training. Russia remains more constrained by geopolitical factors, procurement complexity, regulatory navigation, and supply-chain uncertainty.

China and India represent substantial long-term opportunities due to large diabetes populations and expanding digital health infrastructure, but access depends on pricing, localization, regulatory navigation, physician training, and patient affordability. Japan, Australia, and South Korea show stronger readiness for advanced diabetes technology, supported by high healthcare standards, connected-device adoption, established specialist care pathways, and growing recognition of automated insulin delivery for improving glycemic outcomes and quality of life.

Actionable Recommendations for APDS Industry Leaders

Industry leaders should prioritize clinically validated interoperability, simplified onboarding, and evidence generation that demonstrates improvements in time in range, A1c, hypoglycemia reduction, treatment satisfaction, sleep quality, and quality of life. Product roadmaps should emphasize smaller devices, longer sensor wear, faster warm-up times, improved infusion reliability, lower alarm burden, accessible mobile interfaces, and safe algorithm performance across pediatric, adult, pregnancy, and high-risk user groups.

Commercial teams should build payer-specific value dossiers, support outcomes-based contracting where feasible, and invest in clinician and patient education to reduce adoption friction. Organizations should also strengthen cybersecurity, comply with evolving privacy and medical device regulations, expand multilingual and culturally appropriate support, improve supply-chain resilience, and design pricing and service models that improve access in emerging markets without compromising premium innovation in advanced healthcare systems.

Research Methodology

This executive summary is based on a structured research methodology combining secondary research, regulatory review, clinical literature assessment, reimbursement analysis, and market triangulation. Sources considered include public information from health agencies, diabetes associations, medical device regulators, peer-reviewed clinical studies, reimbursement bodies, healthcare technology assessment agencies, device labeling, clinical guidelines, and technology standards relevant to connected insulin delivery.

Insights were validated by comparing adoption drivers across regions, assessing product and regulatory milestones, and evaluating demand indicators such as diabetes prevalence, type 1 diabetes care needs, continuous glucose monitor penetration, insulin pump access, reimbursement maturity, provider readiness, cybersecurity expectations, and digital health infrastructure. The methodology emphasizes verified, evidence-based interpretation and avoids unsupported market estimates, market sizing, market share, or forecasting claims.

Conclusion

Artificial pancreas device systems are becoming a core pillar of modern diabetes care as connected sensors, insulin pumps, and adaptive algorithms converge into safer, more personalized, and less burdensome therapy. The next phase of the artificial pancreas device system market will be shaped by interoperability, AI-enabled optimization, payer evidence, cybersecurity, usability, and equitable access across advanced and emerging healthcare systems.

Organizations that combine clinical credibility with scalable digital infrastructure, strong regulatory execution, resilient supply chains, and patient-centered design will be best positioned to advance adoption. As healthcare systems prioritize outcomes, chronic disease efficiency, and connected care, APDS technologies are expected to remain central to the future of insulin-dependent diabetes management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Artificial Pancreas Device System Market, by Component
7.1. Introduction
7.2. Control Algorithms
7.2.1. Model Predictive Control
7.2.2. Proportional Integral Derivative Control
7.3. Display Devices
7.3.1. Traditional Handheld Devices
7.3.2. Wearable Display Devices
7.4. Insulin Pumps
7.4.1. Patch Pumps
7.4.2. Tubed Pumps
7.4.3. Tubeless Pumps
7.5. Sensors
7.5.1. Glucose Sensors
7.5.2. Insulin Sensors
8. Artificial Pancreas Device System Market, by Indication
8.1. Introduction
8.2. Type 1 Diabetes
8.3. Type 2 Diabetes
9. Artificial Pancreas Device System Market, by Device Type
9.1. Introduction
9.2. Closed Loop Systems
9.3. Hybrid Closed Loop Systems
9.4. Open Loop Systems
10. Artificial Pancreas Device System Market, by Treatment Type
10.1. Introduction
10.2. Insulin-Only Systems
10.3. Bi-Hormonal Systems
10.4. Hybrid Hormonal Systems
11. Artificial Pancreas Device System Market, by System Type
11.1. Introduction
11.2. Fully Automated Systems
11.3. Semi-Automated Systems
11.4. Manual Systems
12. Artificial Pancreas Device System Market, by End User
12.1. Introduction
12.2. Diagnostic Centers
12.3. Homecare Settings
12.4. Hospitals
12.5. Medical Research Institutes
13. Artificial Pancreas Device System Market, by Sales Channel
13.1. Introduction
13.2. Direct Sales
13.3. Distributors
13.4. Online Retailers
14. Artificial Pancreas Device System Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Artificial Pancreas Device System Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Artificial Pancreas Device System Market, by Country
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Abbott Laboratories
18.2. Admetsys Corporation
18.3. B. Braun Melsungen AG
18.4. Beta Bionics, Inc.
18.5. Bigfoot Biomedical Inc.
18.6. Cellnovo Group SA
18.7. Defymed SAS
18.8. Dexcom, Inc.
18.9. Diabeloop SA
18.10. DreaMed Diabetes Ltd.
18.11. Eli Lilly and Company
18.12. F. Hoffmann-La Roche Ltd
18.13. Glooko, Inc.
18.14. Glytec, LLC
18.15. Inreda Diabetic B.V.
18.16. Insulet Corporation
18.17. Johnson & Johnson
18.18. Medtronic PLC
18.19. Medtrum Technologies Inc.
18.20. MicroTech Medical Co., Ltd.
18.21. NIKKISO Co., Ltd.
18.22. Pancreum, Inc.
18.23. Renfrew Group International
18.24. Securecell AG
18.25. Senseonics Holdings, Inc.
18.26. Sequel Med Tech, LLC
18.27. SOOIL Development Co., Ltd.
18.28. Tandem Diabetes Care, Inc.
18.29. The Menarini Group
19. Key Experts
List of Figures
FIGURE 1. Global Artificial Pancreas Device System Market, Years Considered for the Study
FIGURE 2. Global Artificial Pancreas Device System Market, Research Design
FIGURE 3. Global Artificial Pancreas Device System Market, Research Framework
FIGURE 4. Global Artificial Pancreas Device System Market, Data Triangulation
FIGURE 5. Global Artificial Pancreas Device System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Artificial Pancreas Device System Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global Artificial Pancreas Device System Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Artificial Pancreas Device System Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 9. Global Artificial Pancreas Device System Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Artificial Pancreas Device System Market Size, by Device Type, 2025 vs 2032 (%)
FIGURE 11. Global Artificial Pancreas Device System Market Size, by Device Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Artificial Pancreas Device System Market Size, by Treatment Type, 2025 vs 2032 (%)
FIGURE 13. Global Artificial Pancreas Device System Market Size, by Treatment Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Artificial Pancreas Device System Market Size, by System Type, 2025 vs 2032 (%)
FIGURE 15. Global Artificial Pancreas Device System Market Size, by System Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Artificial Pancreas Device System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Artificial Pancreas Device System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Artificial Pancreas Device System Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 19. Global Artificial Pancreas Device System Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Artificial Pancreas Device System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Artificial Pancreas Device System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Artificial Pancreas Device System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Artificial Pancreas Device System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Artificial Pancreas Device System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Artificial Pancreas Device System Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Artificial Pancreas Device System Market Segmentation & Coverage
TABLE 2. Global Artificial Pancreas Device System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Control Algorithms Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Control Algorithms Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Control Algorithms Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Model Predictive Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Model Predictive Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Model Predictive Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Proportional Integral Derivative Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Proportional Integral Derivative Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Proportional Integral Derivative Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Display Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Display Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Display Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Traditional Handheld Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Traditional Handheld Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Traditional Handheld Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Wearable Display Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Wearable Display Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Wearable Display Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Insulin Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Insulin Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Insulin Pumps Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Patch Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Patch Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Patch Pumps Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Tubed Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Tubed Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Tubed Pumps Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Tubeless Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Tubeless Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Tubeless Pumps Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Sensors Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Sensors Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Sensors Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Glucose Sensors Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Glucose Sensors Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Glucose Sensors Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Insulin Sensors Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Insulin Sensors Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Insulin Sensors Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 44. Global Type 1 Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Type 1 Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Type 1 Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Type 2 Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Type 2 Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Type 2 Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 51. Global Closed Loop Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Closed Loop Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Closed Loop Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Hybrid Closed Loop Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Hybrid Closed Loop Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Hybrid Closed Loop Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Open Loop Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Open Loop Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Open Loop Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 61. Global Insulin-Only Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Insulin-Only Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Insulin-Only Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Bi-Hormonal Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Bi-Hormonal Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Bi-Hormonal Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Hybrid Hormonal Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Hybrid Hormonal Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Hybrid Hormonal Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 71. Global Fully Automated Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Fully Automated Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Fully Automated Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Semi-Automated Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Semi-Automated Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Semi-Automated Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Manual Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Manual Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Manual Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Medical Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Medical Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Medical Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 94. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Online Retailers Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Online Retailers Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Online Retailers Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Artificial Pancreas Device System Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Artificial Pancreas Device System Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 116. North America Artificial Pancreas Device System Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. North America Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 118. North America Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 119. North America Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 120. North America Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 121. North America Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 122. North America Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 123. North America Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 124. North America Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 125. North America Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 126. North America Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. North America Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 128. Latin America Artificial Pancreas Device System Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Latin America Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 130. Latin America Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 131. Latin America Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 132. Latin America Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 133. Latin America Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 134. Latin America Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 135. Latin America Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 136. Latin America Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 137. Latin America Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 138. Latin America Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Latin America Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 140. Europe Artificial Pancreas Device System Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Europe Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 142. Europe Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 143. Europe Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 144. Europe Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 145. Europe Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 146. Europe Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 147. Europe Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 148. Europe Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 149. Europe Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 150. Europe Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Europe Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 152. Middle East Artificial Pancreas Device System Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Middle East Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 154. Middle East Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 155. Middle East Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 156. Middle East Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 157. Middle East Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 158. Middle East Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 159. Middle East Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 160. Middle East Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 161. Middle East Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 162. Middle East Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Middle East Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 164. Africa Artificial Pancreas Device System Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Africa Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 166. Africa Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 167. Africa Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 168. Africa Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 169. Africa Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 170. Africa Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 171. Africa Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 172. Africa Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 173. Africa Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 174. Africa Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Africa Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 176. Global Artificial Pancreas Device System Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. ASEAN Artificial Pancreas Device System Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. ASEAN Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 179. ASEAN Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 180. ASEAN Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 181. ASEAN Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 182. ASEAN Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 183. ASEAN Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 184. ASEAN Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 185. ASEAN Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 186. ASEAN Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 187. ASEAN Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. ASEAN Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 189. GCC Artificial Pancreas Device System Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. GCC Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 191. GCC Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 192. GCC Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 193. GCC Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 194. GCC Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 195. GCC Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 196. GCC Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 197. GCC Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 198. GCC Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 199. GCC Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. GCC Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 201. European Union Artificial Pancreas Device System Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. European Union Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 203. European Union Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 204. European Union Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 205. European Union Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 206. European Union Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 207. European Union Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 208. European Union Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 209. European Union Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 210. European Union Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 211. European Union Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. European Union Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 213. BRICS Artificial Pancreas Device System Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. BRICS Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 215. BRICS Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 216. BRICS Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 217. BRICS Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 218. BRICS Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 219. BRICS Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 220. BRICS Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 221. BRICS Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 222. BRICS Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 223. BRICS Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. BRICS Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 225. G7 Artificial Pancreas Device System Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. G7 Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 227. G7 Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 228. G7 Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 229. G7 Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 230. G7 Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 231. G7 Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 232. G7 Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 233. G7 Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 234. G7 Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 235. G7 Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. G7 Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 237. NATO Artificial Pancreas Device System Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. NATO Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 239. NATO Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 240. NATO Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 241. NATO Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 242. NATO Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 243. NATO Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 244. NATO Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 245. NATO Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 246. NATO Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 247. NATO Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. NATO Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 249. Global Artificial Pancreas Device System Market Size, by Country, 2017-2032 (USD Million)
TABLE 250. United States Artificial Pancreas Device System Market Size, 2017-2032 (USD Million)
TABLE 251. United States Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 252. United States Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 253. United States Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 254. United States Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 255. United States Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 256. United States Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 257. United States Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 258. United States Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 259. United States Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 260. United States Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. United States Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 262. Canada Artificial Pancreas Device System Market Size, 2017-2032 (USD Million)
TABLE 263. Canada Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 264. Canada Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 265. Canada Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 266. Canada Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 267. Canada Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 268. Canada Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 269. Canada Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 270. Canada Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 271. Canada Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 272. Canada Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Canada Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 274. Mexico Artificial Pancreas Device System Market Size, 2017-2032 (USD Million)
TABLE 275. Mexico Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 276. Mexico Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 277. Mexico Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 278. Mexico Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 279. Mexico Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 280. Mexico Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 281. Mexico Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 282. Mexico Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 283. Mexico Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 284. Mexico Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Mexico Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 286. Brazil Artificial Pancreas Device System Market Size, 2017-2032 (USD Million)
TABLE 287. Brazil Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 288. Brazil Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 289. Brazil Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 290. Brazil Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 291. Brazil Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 292. Brazil Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 293. Brazil Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 294. Brazil Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 295. Brazil Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 296. Brazil Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. Brazil Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 298. United Kingdom Artificial Pancreas Device System Market Size, 2017-2032 (USD Million)
TABLE 299. United Kingdom Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 300. United Kingdom Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 301. United Kingdom Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 302. United Kingdom Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 303. United Kingdom Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 304. United Kingdom Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 305. United Kingdom Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 306. United Kingdom Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 307. United Kingdom Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 308. United Kingdom Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. United Kingdom Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 310. Germany Artificial Pancreas Device System Market Size, 2017-2032 (USD Million)
TABLE 311. Germany Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 312. Germany Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 313. Germany Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 314. Germany Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 315. Germany Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 316. Germany Artificial Pancreas Device System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 317. Germany Artificial Pancreas Device System Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 318. Germany Artificial Pancreas Device System Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 319. Germany Artificial Pancreas Device System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 320. Germany Artificial Pancreas Device System Market Size, by End User, 2017-2032 (USD Million)
TABLE 321. Germany Artificial Pancreas Device System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 322. France Artificial Pancreas Device System Market Size, 2017-2032 (USD Million)
TABLE 323. France Artificial Pancreas Device System Market Size, by Component, 2017-2032 (USD Million)
TABLE 324. France Artificial Pancreas Device System Market Size, by Control Algorithms, 2017-2032 (USD Million)
TABLE 325. France Artificial Pancreas Device System Market Size, by Display Devices, 2017-2032 (USD Million)
TABLE 326. France Artificial Pancreas Device System Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 327. France Artificial Pancreas Device System Market Size, by Sensors, 2017-2032 (USD Million)
TABLE 328. France Ar

Companies Mentioned

  • Abbott Laboratories
  • Admetsys Corporation
  • B. Braun Melsungen AG
  • Beta Bionics, Inc.
  • Bigfoot Biomedical Inc.
  • Cellnovo Group SA
  • Defymed SAS
  • Dexcom, Inc.
  • Diabeloop SA
  • DreaMed Diabetes Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Glooko, Inc.
  • Glytec, LLC
  • Inreda Diabetic B.V.
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • MicroTech Medical Co., Ltd.
  • NIKKISO Co., Ltd.
  • Pancreum, Inc.
  • Renfrew Group International
  • Securecell AG
  • Senseonics Holdings, Inc.
  • Sequel Med Tech, LLC
  • SOOIL Development Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • The Menarini Group

Table Information

Report AttributeDetails
No. of Pages197
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 418.22 Million
Forecasted Market Value ( USD ) by 2032 $ 686.27 Million
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Artificial Pancreas Device Systems - Global Strategic Business Report - Product Image

Artificial Pancreas Device Systems - Global Strategic Business Report

  • Report
  • 115 Pages
  • Global
From
Artificial Pancreas Device Systems Market Report by Device Type, Treatment Type, End-User, and Region 2026-2034 - Product Image

Artificial Pancreas Device Systems Market Report by Device Type, Treatment Type, End-User, and Region 2026-2034

  • Report
  • 148 Pages
  • Global
From
Artificial Pancreas Device System - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Artificial Pancreas Device System - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 135 Pages
  • Global
From
Artificial Pancreas Device System Market Report 2026 - Product Image

Artificial Pancreas Device System Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Artificial Pancreas Market 2026-2030 - Product Image

Artificial Pancreas Market 2026-2030

  • Report
  • 303 Pages
  • Global
From

About the Artificial Pancreas Market

The Artificial Pancreas is a medical device that uses biomaterials to regulate blood glucose levels in people with diabetes. It is composed of a continuous glucose monitor (CGM) and an insulin pump, which are connected to a computer algorithm that automatically adjusts insulin delivery. The Artificial Pancreas is designed to mimic the natural pancreas, which produces insulin in response to changes in blood glucose levels. The device is intended to reduce the burden of diabetes management and improve glycemic control. The Artificial Pancreas market is growing rapidly, driven by increasing prevalence of diabetes, technological advancements, and increasing awareness of the benefits of the device. The market is expected to be further driven by increasing investments in research and development, and the introduction of new products. Some of the key players in the Artificial Pancreas market include Medtronic, Johnson & Johnson, Insulet Corporation, Dexcom, Tandem Diabetes Care, and Bigfoot Biomedical. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.